The 3 best performing ASX shares of the week of 28 November 2022
Marc Kennis, December 5, 2022
The 3 best performing ASX shares in the week of 28 November 2022
The 3 best performing ASX shares of the week starting 28 November 2022 were Gentrack Group (ASX:GTK), up 47.8%; 4DS Memory (ASX:4DS), up 42.9%; and MedAdvisor (ASX:MDR), up 41.2%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
1. Gentrack Group (ASX:GTK)
Industry: Software & IT Services
Our list of best performing ASX shares this week starts with Gentrack Group (ASX:GTK), which is involved in the design, development, implementation and support of specialist software solutions for energy utilities, water companies and airports mainly in Australia and New Zealand.
Market Cap: $235m
12 month high / low: $1.125 – $2.52
2. 4DS Memory (ASX:4DS)
Industry: Technology
4DS Memory (ASX:4DS) is s a semiconductor development company of non-volatile memory technology, which is involved in research and development of interface Switching ReRAM technology for next generation storage in mobile and cloud. 4DS has facilities located in Silicon Valley. You can also check out all research our parent company Pitt Street Research has conducted on 4DS Memory here.
Market Cap: $52m
12 month high / low: $0.022 – $0.1325
3. MedAdvisor (ASX:MDR)
Industry: Healthcare
MedAdvisor (ASX:MDR) rounds out our list of best performing ASX shares this week. MDR is Australian software systems developer focused on addressing gaps in personal medication adherence. MedAdvisor’s free app connects to pharmacy dispensing systems to automatically retrieve medication records and drive an intelligent training, information and reminder system to ensure correct and reliable medication use.
Market Cap: $131m
12 month high / low: $0.13 – $0.395
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
This company just made an IND submission to the US FDA, here’s why its a big step!
Imagion Biosystems (ASX:IBX) just made a IND submission. This is a big deal for the company, and we thought it…
Amplitude Energy (ASX:AEL) Down 20% After Elanora 1 Misses, Isabella Is the Next Shot
Amplitude Energy The Market Was Positioned for Gas, It Got Water Amplitude Energy (ASX:AEL) saw a sharp sell-off, down around…
Can Traders Learn Anything from Gambling Strategies?
Gamblers have been arguing about the viability of gambling strategies for years. There are those who will argue that they…